<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>771</id><JournalTitle>THERAPEUTIC POTENTIAL OF PHYTOCHEMICALS IN CHRONIC DISEASES: MECHANISTIC INSIGHTS</JournalTitle><Abstract>Chronic diseases, including cardiovascular disorders, diabetes mellitus, cancer, and neurodegenerative conditions, represent
a major global health burden characterized by complex multifactorial etiologies involving oxidative stress, inflammation,
metabolic dysregulation, and genetic alterations. In recent years, phytochemicals—bioactive compounds derived from plants
such as polyphenols, flavonoids, alkaloids, terpenoids, and carotenoids—have gained considerable attention due to their
therapeutic potential in the prevention and management of chronic diseases. These natural compounds exert diverse
pharmacological effects through modulation of key molecular pathways, including antioxidant defense systems,
inflammatory signaling cascades, apoptosis, and cellular metabolism. Phytochemicals such as curcumin, resveratrol,
quercetin, and epigallocatechin gallate have demonstrated significant efficacy in targeting disease-specific mechanisms,
including inhibition of nuclear factor-kappa B (NF-?B), activation of nuclear factor erythroid 2–related factor 2 (Nrf2), and
regulation of mitogen-activated protein kinase (MAPK) pathways. Additionally, emerging evidence highlights the role of
phytochemicals in epigenetic regulation and gut microbiota modulation, further enhancing their therapeutic relevance.
Despite promising preclinical and clinical findings, challenges such as poor bioavailability, rapid metabolism, and
variability in phytochemical content limit their clinical translation. Advances in nanotechnology-based drug delivery
systems and formulation strategies are being explored to overcome these limitations and improve therapeutic efficacy. This
review provides a comprehensive overview of the mechanistic insights underlying the therapeutic potential of
phytochemicals in chronic diseases, emphasizing their molecular targets, pharmacological actions, and future prospects in
integrative medicine and drug development.</Abstract><Email>abhilasharathore0091@gmail.com</Email><articletype>Research</articletype><volume>16</volume><issue>1</issue><year>2026</year><keyword> Phytochemicals; Chronic diseases; Antioxidant activity; Anti-inflammatory mechanisms; Drug delivery systems.</keyword><AUTHORS>Dr. Rathore Abhilasha Ramsingh</AUTHORS><afflication>Assistant professor, Department of Pharmacology, Rajputana College of Pharmacy, Bangalore, Karnataka, India.</afflication></Article></Articles>